Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optune With Concurrent Bevacizumab in Recurrent or Progressive Meningioma
NCT02847559Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Aug 2016
- Primary completion
- Aug 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in meningioma, sponsored by Northwestern University. Started Aug 2016; status: completed.
02
Drugs
bevacizumab
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT02847559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847559.